AHA Coding Clinic® for HCPCS - 2017 Issue 1; For Your Information

New diagnostic radiopharmaceuticals and new contrast agents

Appropriate reporting of new diagnostic radiopharmaceuticals and new contrast agents Hospitals may appropriately report HCPCS code C9399, Unclassified drugs or biologicals, for new drugs, biologicals and therapeutic radiopharmaceuticals, that are approved by the Food and Drug Administration (FDA) on or after January 1, 2004 for which pass-through status has not been approved and a HCPCS C code and APC payment has not been assigned.  However, it would be inappropriate to report HCPCS code C9399 for new diagnostic radiopharmaceuticals and contrast agents prior to the approval of pass-through status. In this instance the new diagnostic radiopharmaceuticals and contrast agents...

To read the full article, sign in and subscribe to the AHA Coding Clinic® for HCPCS.


The AHA Coding Clinic for HCPCS includes:

  • The official publication for Level I HCPCS (CPT-4 codes) for hospital providers
  • Also specific Level II HCPCS codes for hospitals, physicians and other health professionals
  • Current newsletters added each quarter
  • Full Archives back to 2001
  • Fully searchable through Find-A-Code's Comprehensive Search
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information page link back to related articles
  • View all the articles associated with any code, right from the code page!
Access to this feature is available in the following products:
  • AHA's Coding Clinic® - HCPCS +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.